CKD患者血清中巨噬细胞胆固醇外流至肝细胞递送受损可能解释心血管病风险增加
该研究前瞻性纳入健康者、至少1项冠心病危险因素者、确诊冠心病者及CKD G3-G5期患者(每组n≥15),评估血清促进THP1巨噬细胞泡沫细胞胆固醇外流能力(CEC)及将外流胆固醇递送至原代肝细胞的能力(CDCH)。结果发现CKD患者CEC显著升高,而校正CEC后CDCH显著低于冠心病患者,提示逆向胆固醇转运最后一步受损可能解释CKD患者冠心病风险增加。
要点
- CKD患者血清CEC显著高于健康者及冠心病患者。
- 所有组CDCH均低于健康者,CKD患者校正CEC后CDCH显著低于冠心病患者。
- CDCH与年龄、BMI、代谢指标、炎症标志物及肾功能标志物相关。
核心结论
- CKD患者血清将巨噬细胞外流胆固醇递送至肝细胞的能力受损,可能解释其冠心病风险增加。
研究设计与样本
- 前瞻性研究,连续纳入健康者、至少1项冠心病危险因素者、确诊冠心病者及CKD G3-G5期患者,每组n≥15。
- 评估总血清促进THP1巨噬细胞泡沫细胞胆固醇外流能力(CEC)及递送至原代肝细胞(生理表达SR-BI)的能力(CDCH)。
主要发现
- 健康者、至少1项冠心病危险因素者及确诊冠心病者CEC相似,CKD患者CEC显著更高。
- 所有组CDCH均显著低于健康者;校正较高CEC后,CKD患者CDCH显著低于冠心病患者。
- CDCH与年龄、体质指数、代谢参数、炎症标志物及肾功能标志物(eGFR、血清肌酐、血清胱抑素C)相关。
临床怎么用
- 在CKD患者心血管风险评估中,可关注逆向胆固醇转运最后一步(递送至肝细胞)受损。
- CEC升高而CDCH降低提示需综合评估胆固醇外流与递送功能,而非仅看CEC。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although chronic kidney disease (CKD) is associated with increased risk for coronary artery disease (CAD), the underlying mechanisms are not completely defined. In the present study, we tested the hypothesis that flux of cholesterol from macrophage foam cells to liver is impaired in subjects with CKD. METHODS: Consecutive healthy patients, patients with at least 1 CAD risk factor, patients with established CAD, and patients with CKD stages G3 to G5 (n ≥ 15/group) were recruited prospectively. The ability of total patient serum without any modifications to (i) facilitate efflux of cholesterol from human THP1-macrophage foam cells under physiological conditions (cholesterol efflux capacity [CEC]) and (ii) to deliver this effluxed cholesterol to primary hepatocytes with physiological expression of high-density lipoprotein (HDL) receptor SR-BI (capacity to deliver cholesterol to hepatocytes [CDCH]) was evaluated. RESULTS: Although healthy patients, patients with at least 1 CAD risk factor, and patients with established CAD all showed similar CEC, patients with CKD showed significantly higher CEC. CDCH was significantly lower in all groups compared with the healthy patients; however, when corrected for higher CEC, CDCH in patients with CKD was significantly lower than in patients with CAD. CDCH correlated with age, body mass index, metabolic parameters, inflammatory markers, and kidney function markers (estimated glomerular filtration rate [eGFR], serum creatinine, and serum cystatin C). CONCLUSIONS: These results suggest that aberrations in delivery of cholesterol effluxed from macrophage foam cells to liver for final elimination or the last step of reverse cholesterol transport, may underlie the increased risk of CAD in patients with CKD.
引用
- Gipson GT, Carbone S, Wang J, et al. Impaired Delivery of Cholesterol Effluxed From Macrophages to Hepatocytes by Serum From CKD Patients May Underlie Increased Cardiovascular Disease Risk. Kidney Int Rep. 2019. PMID: 32043034. doi:10.1016/j.ekir.2019.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。